Related Experiment Video
Updated: Feb 8, 2026

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
Published on: August 19, 2025
Fungal exposure in homes of patients with sarcoidosis - an environmental exposure study
Marjeta Terčelj1, Barbara Salobir, Matevz Harlander
1Clinic of Respiratory Diseases and Allergy, University Medical Centre, Ljubljana, Slovenia. marjeta.tercelj@kclj.si
Background:
There is increasing evidence that exposure to moulds (fungi) may influence the development of sarcoidosis. To assess the influence of the environmental exposure, a study was undertaken to determine the exposure to fungi in homes of subjects with sarcoidosis.
Methods:
Subjects were patients with clinically established sarcoidosis recruited during the period September 2007 till June 2010. Of these 55 were newly diagnosed and currently under treatment for less than one year, 25 had been treated and had no recurrence and 27 had been treated but had recurrence of the disease. Controls were healthy subjects without any respiratory symptoms (n = 30). Samples of air (about 2.5 m3) were taken in the bedroom of the subjects using a portable pump and cellulose ester filters. The filters were analysed for the content of the enzyme N-acetylhexosaminidase (NAHA) as a marker of fungal cell biomass, using a specific substrate and a fluorescent technique and expressed as NAHA units (U)/m3.
Results:
Compared to controls, subjects undergoing treatment of the disease (newly diagnosed or with recurrence) had significantly higher activities of NAHA in their homes than controls (33.6 and 39.9 vs 10.0 U/m3, p < 0.001 and <0.001). Among controls only 5 out of 30 subjects had levels of NAHA above the second quartile value (14 U/m3). In homes of subjects with newly diagnosed disease with treatment less than one year, values above 14 NAHA U/m3 were found among 35 out of 55 and among those with recurrent disease among 18 out of 27.
Conclusions:
The higher activities of NAHA enzyme found in homes of subjects with active and recurrent sarcoidosis suggest that exposure to fungi is related to the risk of sarcoidosis. Further environmental studies to assess the importance of this exposure for subjects with sarcoidosis are warranted. The results suggest that remedial actions in homes with high levels of fungi may be justified.
Insights
Fungal exposure in homes is linked to sarcoidosis. Higher enzyme levels (NAHA) in homes of sarcoidosis patients suggest a connection between fungi and disease risk, warranting further study and potential home remediation.
Area of Science:
- Environmental Health
- Mycology
- Pulmonary Medicine
Background:
- Emerging evidence links mold (fungi) exposure to sarcoidosis development.
- Environmental factors are increasingly recognized as potential influences on sarcoidosis.
Purpose of the Study:
- To investigate the level of fungal exposure in the homes of individuals diagnosed with sarcoidosis.
- To determine if a correlation exists between home fungal biomass and sarcoidosis status.
Main Methods:
- Air samples were collected from bedrooms of sarcoidosis patients and healthy controls.
- N-acetylhexosaminidase (NAHA) enzyme activity was measured as a marker for fungal biomass.
- NAHA levels were expressed in units per cubic meter (U/m3).
Main Results:
- Significantly higher NAHA activities were observed in homes of sarcoidosis patients compared to controls (33.6 and 39.9 U/m3 vs. 10.0 U/m3).
- A majority of newly diagnosed (35/55) and recurrent (18/27) sarcoidosis patients had elevated NAHA levels (>14 U/m3) in their homes.
- Only 5 out of 30 healthy controls exhibited NAHA levels above the second quartile value.
Conclusions:
- Elevated NAHA enzyme activities in homes of active and recurrent sarcoidosis patients suggest a link between fungal exposure and sarcoidosis risk.
- Further environmental research is recommended to fully understand the significance of fungal exposure for sarcoidosis patients.
- Intervention strategies to reduce fungal levels in homes may be beneficial for individuals with sarcoidosis.
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Fungal Phylum Ascomycota
Fungal Phylum Basidiomycota
Environmental Applications of Microorganisms
Fungal Phylum Microsporidia
Fungal Group Zygomycota

